Blog

Explore key takeaways from the Consortium’s first in-person meeting at the Onsemble Conference and welcome new members.

The 2022 Onsemble Conference provided an opportunity for attendees to reconnect in person and collaborate to move research forward.

Responses to the most frequently asked questions regarding mRNA technology and clinical trial regulatory requirements.

This blog outlines critical events where EACs are used to look at more than just “endpoints” in clinical research.

Take a closer look at how and why we leverage proprietary, custom, and intelligent technology in our EAC program

Advarra's Sergio Armani introduces ACRP's Ride for Diversity program and why it's important to him personally and to the research community.

Explore what digital acceleration means for clinical research and how Advarra views digital transformation in the industry.

This blog outlines when a device clinical trial sponsor should engage an EAC or CEC to provide specific medical expertise & safety oversight.

The new European Union regulations have significant implications for sponsors submitting trials in the EU.

This newsletter outlines the Consortium's efforts to improve regulatory workflows in study startups.

Encouraging site-owned technology platforms enables site staff to produce their best work, increasing the likelihood of a study’s success.

Read this blog to learn IRB review considerations for artificial intelligence and machine learning studies.